During an open public hearing before the vote, the panel heard from multiple speakers, including public health advocates, physicians, and peptide companies, who expressed widely differing views on whether BPC-157 should be included on the 503A bulk drug list
Sections 503A and 503B of the FD&C Act allow pharmacies and registered outsourcing facilities (facilities registered with the FDA under Section 503B that may compound larger volumes of drugs without individual patient prescriptions), respectively, to compound customized medications but not copies of commercially available drugs, unless those drugs are on the FDAs shortage list (a publicly available, regularly updated database identifying drugs whose national supply cannot meet current demand)
Because GHK-Cu relies on signaling rather than chemically exfoliating the skin, it takes time for the collagen cycle to turn over
Usage Instructions of Bacteriostatic (BAC) Water To Reconstitute (Dissolve) Freeze-Dried Peptide Powders for Injection Use only if instructed by a qualified clinician
